Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.19
+0.47 (4.38%)
Nov 4, 2024, 4:00 PM EST - Market closed
Artiva Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 272 | - | - | - | - | - |
| Enterprise Value | 446 | - | - | - | - | - |
| Debt / Equity Ratio | 0.62 | 0.31 | 0.26 | 0.01 | 0.13 | -1.97 |
| Debt / FCF Ratio | -0.31 | -0.33 | -0.34 | -0.10 | -0.15 | -2.27 |
| Asset Turnover | - | 0.28 | 0.03 | 0.02 | - | - |
| Quick Ratio | 4.44 | 6.45 | 4.02 | 8.36 | 4.41 | 1.99 |
| Current Ratio | 4.59 | 6.53 | 4.08 | 8.41 | 4.53 | 2.08 |
| Return on Equity (ROE) | - | -44.15% | -57.84% | -99.72% | -286.85% | - |
| Return on Assets (ROA) | - | -16.10% | -24.68% | -33.44% | -67.03% | - |
| Return on Capital (ROIC) | - | -23.03% | -33.32% | -45.02% | -101.60% | - |
| Buyback Yield / Dilution | -5.55% | -4.70% | -11.80% | -8.60% | -3.59% | - |
| Total Shareholder Return | -5.55% | -4.70% | -11.80% | -8.60% | -3.59% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.